Literature DB >> 23622013

Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma.

Tomoko Tajiri, Hisako Matsumoto, Harukazu Hiraumi, Hiroki Ikeda, Kyohei Morita, Kenji Izuhara, Junya Ono, Shoichiro Ohta, Isao Ito, Tsuyoshi Oguma, Hitoshi Nakaji, Hideki Inoue, Toshiyuki Iwata, Tadao Nagasaki, Yoshihiro Kanemitsu, Juichi Ito, Akio Niimi, Michiaki Mishima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23622013     DOI： 10.1016/j.anai.2013.01.024

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  16 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Is there a future for biologics in the management of chronic rhinosinusitis?

Authors:  Kent Lam; Robert C Kern; Amber Luong
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-22       Impact factor: 3.858

Review 3.  Current and Future Treatments of Rhinitis and Sinusitis.

Authors:  Gayatri B Patel; Robert C Kern; Jonathan A Bernstein; Park Hae-Sim; Anju T Peters
Journal:  J Allergy Clin Immunol Pract       Date:  2020-01-28

Review 4.  Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.

Authors:  Joshua M Levy; Luke Rudmik; Anju T Peters; Sarah K Wise; Brian W Rotenberg; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-02       Impact factor: 3.858

Review 5.  Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.

Authors:  Michelle Fox Huffaker; Wanda Phipatanakul
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

6.  Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.

Authors:  Jin-Young Min; Christopher J Ocampo; Whitney W Stevens; Caroline P E Price; Christopher F Thompson; Tetsuya Homma; Julia H Huang; James E Norton; Lydia A Suh; Kathryn L Pothoven; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Nikolai N Modyanov; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-10-04       Impact factor: 10.793

7.  Biologics for chronic rhinosinusitis.

Authors:  Lee-Yee Chong; Patorn Piromchai; Steve Sharp; Kornkiat Snidvongs; Katie E Webster; Carl Philpott; Claire Hopkins; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2021-03-12

8.  Biologics for chronic rhinosinusitis.

Authors:  Lee-Yee Chong; Patorn Piromchai; Steve Sharp; Kornkiat Snidvongs; Carl Philpott; Claire Hopkins; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

Review 9.  Role of periostin in ECRS.

Authors:  Lei Yu; Jisheng Wang; Kai Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-21       Impact factor: 2.503

Review 10.  Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review.

Authors:  Gennaro D'Amato; Anna Stanziola; Alessandro Sanduzzi; Gennaro Liccardi; Antonello Salzillo; Carolina Vitale; Antonio Molino; Alessandro Vatrella; Maria D'Amato
Journal:  Multidiscip Respir Med       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.